← Eichor
Condition: Desmoid Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Desmoid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cryotherapy in the Treatment of Desmoid Tumors
NA · 1 location(s) · Istituto Ortopedico Rizzoli · NCT05091255Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT06224283Treatment of Desmoid Fibromatosis With Arterial Embolization
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT06945887Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Phase 2 · 1 location(s) · Sarcoma Oncology Research Center, LLC · NCT03886311FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence i
Phase 2 · 2 location(s) · michal roll · NCT01898416Study of Cryoablation and Nirogacestat for Desmoid Tumor
Phase 2 · 1 location(s) · Nam Bui · NCT05949099Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT06268457Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Phase 4 · 23 location(s) · SpringWorks Therapeutics, Inc., a healthcare company of Merc · NCT07176689Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Phase 1/Phase 2 · 17 location(s) · Recursion Pharmaceuticals Inc. · NCT05552755Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05879146Observing People With Desmoid-Type Fibromatosis
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04281381A Study in Adults With Desmoid Tumors
Phase 2 · 1 location(s) · Elpiscience (Suzhou) Biopharma, Ltd. · NCT07541430HIFU Ablation of Soft Tissue Sarcoma
NA · 1 location(s) · Oxford University Hospitals NHS Trust · NCT05111964Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Project: Every Child for Younger Patients With Cancer
Phase N/A · 278 location(s) · Children's Oncology Group · NCT02402244Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Phase N/A · 8 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT07496242Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
NA · 13 location(s) · University Hospital, Strasbourg, France · NCT06081400
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.